Changing Faces: Pharma and biotech hires, September 2026
There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.
Newsletters and Deep Dive digital magazine
There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.
The Nobel Prize in Chemistry 2026 has been awarded to Henri B Kagan and Kensō Soai for their discoveries in asymmetric organic synthesis.
Just months after launching an open-source 'virtual biology' platform, Biohub has raised $1.8 billion in backing for the AI-powered initiative.
Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.
There may be a fairly buoyant operating environment for biotechs in the US, but Adecto and Aviceda are winding down, while Caribou is in peril.
Editor's Picks
Newsletters and Deep Dive
digital magazine